Bizarre Patents
Method and apparatus for making a drink hop along a bar or counter
A method for generating a drink which appears to hop from a remote spot on the bar or counter and take one or more leaps, before landing in a patron's glass.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8119642 | Structurally rigid dopamine D3 receptor selective ligands and process for making them A family of structurally rigid dopamine D3 receptor selective ligands is described. The family of structurally rigid dopamine D3 receptor selective ligands has the formula wherein A is cis or trans —CH═CH—, —C═C—, or cyclohexyl. B is cis or trans —CH... | 02/21/2012 |
| 7838527 | Methods of treating cancer and related methods Methods of treating cancer using 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one are provided. In particular, the methods are effective for the treatment of solid tumors or leukemias, including prostate, colorectal, breast, mul... | 11/23/2010 |
| 7820676 | Diketopiperazine salts for drug delivery and related methods Drug delivery systems have been developed based on the formation of diketopiperazine carboxylate salts and microparticles containing the same. The systems may further comprise a bioactive agent. Related methods for making and using the biologically active agent deli... | 10/26/2010 |
| 7763620 | Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment The present invention relates to piperazinone compounds, pharmaceutical compositions containing those compounds and methods of treating tumors and cancer, among other disease states and conditions in mammalian patients, especially including humans. ... | 07/27/2010 |
| 7517884 | Sulfonyl-substituted bicyclic compounds as modulators of PPAR Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed. ... | 04/14/2009 |
| 7494999 | Sulfonyl-substituted bicyclic compounds as modulators of PPAR Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed. ... | 02/24/2009 |
| 7332153 | Cosmetic compositions Cosmetic formulations containing a cosmetic active and a continuous phase comprising a water-immiscible liquid carrier, such as, amongst other materials, silicone oils, branched aliphatic alcohols or liquid aromatic/aliphatic esters that is structured by a cyclodipe... | 02/19/2008 |
| 7288545 | Piperazinedione compounds This invention relates to a method for treating an angiogenesis-related disease. The method includes administering to a subject in need thereof an effective amount of a piperazinedione compound having the formula: | 10/30/2007 |
| 7265108 | Nitrogen containing heterocyclic compounds and medicines containing the same Compounds represented by the following general formula: [wherein X1, X2, X3 and X4 each independently represent a single bond, C1-6 alkylene, etc.; A2 | 09/04/2007 |
| 7262211 | Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation Novel compounds having activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful in ... | 08/28/2007 |
| 7223751 | Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same The present invention relates to a novel sulfonamide derivatives and novel intermediates thereof, preparation thereof, and a pharmaceutical composition comprising the same, and more particularly, to novel sulfonamide derivatives and intermediates thereof that are us... | 05/29/2007 |
| 7119203 | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors This invention is directed generally to proteinase (also known as “protease”) inhibitors, and, more particularly, to piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids that, inter alia, inhibit matrix metalloproteinase (also known as “matrix metallop... | 10/10/2006 |
| 7115611 | Phenyl derivatives, their manufacture and use as pharmaceutical agents This invention relates to compounds of the formula wherein one of R5, R6 and R7 is | 10/03/2006 |
| 7109200 | Carbamate derivatives, process for producing the same and use thereof Novel carbamate derivatives which are useful as drugs because of inhibiting activated blood coagulation factor X and thus exerting an anticoagulant effect. Compounds represented by the formula: wherein R1 | 09/19/2006 |
| 7105507 | Cyclohexane derivatives and their use as therapeutic agents The present invention relates compounds of formula (I), wherein ring A is a phenyl or pyridyl ring; X represents a linker selected from the group consisting of formulae: (a), (b), (c), (d), and (e); and R1, R2, R3, R4, R | 09/12/2006 |
| 7094778 | Heterocyclylalkylamines as muscarinic receptor antagonists This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I: wherein X, Y, and Z are O, S or NR5, and the other substituents are... | 08/22/2006 |
| 7067670 | Sulfamato hydroxamic acid metalloprotease inhibitor A sulfamato hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a process for preparing the same, intermediate compounds useful in those syntheses, and a treatment process that comprises administering a contemplated ... | 06/27/2006 |
| 7056934 | Nicotinamide derivatives useful as PDE4 inhibitors This invention relates to nicotinamide derivatives of general formula (I): in which R1, R2 and R3 have the meanings defined herein, and to processes for the preparation of, interm... | 06/06/2006 |
| 6989383 | Method of treating cancer The present invention relates to methods of treating cancer using a combination of a compound which is an antineoplastic agent and a compound which is a inhibitor of prenyl-protein transferase, which methods comprise administering to said mammal, either sequentially... | 01/24/2006 |
| 6972287 | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits The present invention provides a method of treating Alzheimer's disease using a compound of Formula (I). Also provided is a method of inhibiting the aggregation of amyloid proteins using a compound of the Formula (I) and a method of imaging amyloid deposits, as well... | 12/06/2005 |
| 6967202 | Method of synthesizing diketopiperazines The invention provides a method of synthesizing a diketopiperazine of the formula: wherein: R1 is —CH2COR3, or —CH2CH2COR | 11/22/2005 |
| 6916816 | Phenanthryl piperazinyl dicarboxylic acids as selective NMDA receptor modulating agents Disclosed are compounds of formula (I) wherein: L is (a) optionally substituted by replacement of one or more of the hydrogen atoms on the phenanthrene ring system by one or more groups other than hydrogen; A is CH2, SO2 or C═O; X is CO2... | 07/12/2005 |
| 6900213 | Bisaryl derivatives having FSH modulatory activity The invention relates to bisaryl derivatives of the formula I, wherein (R,R) is selected from (H,H), O, (H,CH3), (H,OH) and (H,CN); Ar is substituted phenyl and A is a group of formula II, III, IV ... | 05/31/2005 |
| 6878707 | Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion Compounds of formula (I) wherein R2—C, R3—C, R4—C or R5—C may be replaced by N; and wherein n is 1, 2 or 3; R1 is aryl, heteroaryl or (aryl or heteroaryl)-lo... | 04/12/2005 |
| 6818645 | Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I: wherein X, Y, and Z are O, S, or NR4, and the other substituents are as d... | 11/16/2004 |
| 6762178 | Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors Hydroxamic acids having the formula are useful in treating disease conditions mediated by TNF-α, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and de... | 07/13/2004 |
| 6734184 | Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13. ... | 05/11/2004 |
| 6730783 | Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitors Aminoguanidine and alkoxyguanidine compounds, including compounds of the formula: wherein X is O or NR9 and R1-R4, R6-R9, R11, R12, Ra | 05/04/2004 |
| 6706745 | Biphenylamidine derivatives The present invention relates to a biphenylamidine derivative of the general formula (1): or a pharmaceutically acceptable salt thereof, which is a novel compound functioning as a clinically applicable FXa inhibitor.... | 03/16/2004 |
| 6693100 | Pharmaceutical compositions for treating psoriasis The use for the manufacture of a medicament for treating psoriasis of dexrazoxane, the d-isomer of 1,2-bis(3,5-dioxopiperazin-1-yl)-propane, or a physiologically acceptable salt thereof.... | 02/17/2004 |
| 6686349 | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors The invention relates to novel tetracyclic pyrroloquinolone derivatives of the formula (I) or (II): ##STR1## wherein all variables are as herein defined, pharmaceutical compositions containing the compounds and their use for the treatment of sexual d... | 02/03/2004 |
| 6680312 | Sulfonamide derivatives, their production and use The present invention is to provide a compound or a salt thereof represented by the formula: ##STR1## wherein R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, the ring A is an optionally su... | 01/20/2004 |
| 6677336 | Substituted piperazine compounds Novel compounds of the general formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subse... | 01/13/2004 |
| 6673811 | 1H-pyrrolo [3,2-b] pyridine-3-carboxylic acid amines as GABAA receptor ligands Disclosed are 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid amides that bind to the benzodiazepine site of GABAA receptors. Such compounds can be used to modulate ligand binding to GABAA receptors in vivo and in vitro, and are particul... | 01/06/2004 |
| 6642225 | Diazacycloalkanedione derivatives Compounds of formula I ##STR1## wherein R is carboxy, esterified carboxy or amidated carboxy; R1 and R3 are independently lower alkyl, (hydroxy, lower alkoxy, amino, acylamino, mono- or di-lower alkylamino or mercapto)-lower alkyl, ... | 11/04/2003 |
| 6638931 | Aminoguanidines and alkoxyguanidines as protease inhibitors Aminoguanidine and alkoxyguanidine compounds, including compounds of the formula: ##STR1## wherein X is O or NR9 and R1 -R4, R6 -R9, R11, R12, Ra, Rb, R | 10/28/2003 |
| 6555543 | Method of using diketopiperazines and composition containing them The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also pro... | 04/29/2003 |
| 6525042 | Sulfonyl derivatives Sulfonyl derivatives represented by general formula (I), salts of the same, and solvates of both: and application of them as drugs: [wherein R1 is hydrogen, hydroxyl, nitro or the like; R2 and R3 are each independently hyd... | 02/25/2003 |
| 6518310 | Aminoguanidines and alkoxyguanidines as protease inhibitors Aminoguanidine and alkoxyguanidine compounds, including compounds of the formula: ##STR1## wherein X is O or NR9 and R1 -R4, R6 -R9, R11, R12, Ra, Rb, R | 02/11/2003 |
| 6509337 | Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors A compound of the formula ##STR1## wherein R1 -R9 and Ar are as defined above, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, tissue ulceration, restenosis, periodontal disease, epidem... | 01/21/2003 |
